|
Volumn 42, Issue 5, 2007, Pages 320-324
|
Clinical analysis of 42 cases of primary malignant melanoma in female genital tract
a a a a a a
a
CANCER HOSPITAL
(China)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
MELANOMA SPECIFIC ANTIGENS;
MELANOMA-SPECIFIC ANTIGENS;
PROTEIN S 100;
TUMOR ANTIGEN;
TUMOR PROTEIN;
UNCLASSIFIED DRUG;
ADJUVANT CHEMOTHERAPY;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CANCER STAGING;
DISEASE FREE SURVIVAL;
FEMALE;
FEMALE GENITAL TRACT TUMOR;
HUMAN;
IMMUNOHISTOCHEMISTRY;
LYMPHADENECTOMY;
MELANOMA;
METABOLISM;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
PROGNOSIS;
RADIOTHERAPY;
RETROSPECTIVE STUDY;
UTERINE CERVIX TUMOR;
VAGINA TUMOR;
VULVA TUMOR;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTIGENS, NEOPLASM;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHEMOTHERAPY, ADJUVANT;
COMBINED MODALITY THERAPY;
DISEASE-FREE SURVIVAL;
FEMALE;
GENITAL NEOPLASMS, FEMALE;
HUMANS;
IMMUNOHISTOCHEMISTRY;
LYMPH NODE EXCISION;
MELANOMA;
MIDDLE AGED;
NEOPLASM PROTEINS;
NEOPLASM STAGING;
PROGNOSIS;
RADIOTHERAPY;
RETROSPECTIVE STUDIES;
S100 PROTEINS;
UTERINE CERVICAL NEOPLASMS;
VAGINAL NEOPLASMS;
VULVAR NEOPLASMS;
|
EID: 53749092443
PISSN: 0529567X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (0)
|